Phylloceuticals2
Phylloceuticals2
  • Home
  • Our Team
    • OUR TEAM
    • Bill Brydges, M.S.
    • Dan Hanson, M.S.
    • R. Barry Holtz, Ph.D.
    • Susan Stipa
    • Mark Brown, Ph.D.
    • Lynn Dickey, Ph.D.
    • Curt Cornwell
    • Kathleen Brunner
  • Technology
  • Markets
  • News
    • News
    • Phylloside Chats
    • Press Release
  • Contact Us
  • More
    • Home
    • Our Team
      • OUR TEAM
      • Bill Brydges, M.S.
      • Dan Hanson, M.S.
      • R. Barry Holtz, Ph.D.
      • Susan Stipa
      • Mark Brown, Ph.D.
      • Lynn Dickey, Ph.D.
      • Curt Cornwell
      • Kathleen Brunner
    • Technology
    • Markets
    • News
      • News
      • Phylloside Chats
      • Press Release
    • Contact Us
  • Home
  • Our Team
    • OUR TEAM
    • Bill Brydges, M.S.
    • Dan Hanson, M.S.
    • R. Barry Holtz, Ph.D.
    • Susan Stipa
    • Mark Brown, Ph.D.
    • Lynn Dickey, Ph.D.
    • Curt Cornwell
    • Kathleen Brunner
  • Technology
  • Markets
  • News
    • News
    • Phylloside Chats
    • Press Release
  • Contact Us

VIDEOCASTS

Drug Solutions Podcast: Biologic Drug Development and Manufacturing

In this episode of the Drug Solutions Podcast, Feliza Mirasol, Pharmaceutical Technology’s science editor, discusses technologies enabling biologics and emerging therapies manufacturing and development with Barry Holtz, PhD, chief scientific officer of Phylloceuticals, and Professor Yaakov Nahmias, founder and chief scientific officer, Tissue Dynamics and founder and president, Future Meat Technologies.

End in Mind at the Beginning

Kathleen Brunner from Acumen Analytics discusses how important it is to keep the end in mind at the beginning with any process by involving artificial intelligence. This strategy eliminates informational roadblocks and improves pharmaceutical production.

Centralized Location for Information

Kathleen Brunner from Acumen Analytics discusses how important a centralized location for data is, especially in the life science field.

A Lot of Great Science

Dr. Jeanne Novak discusses how the science of PMP was demonstrated to the FDA. 

First PMP Vaccine with FDA

Dr. Jeanne Novak speaks on the first PMP vaccine developed and why it was so important in the FDA approval process. 

A Friendship that involves Plant Made Pharmaceuticals

Special guest Jeanne Novak, Ph.D. joined Dr. Barry Holtz on Phylloside chats.

The History of Plant Made Pharmaceuticals

Dr. Barry Holtz discusses how COVID-19 revealed food and pharma insecurity around the globe.

Food: Pharma Insecurity

Dr. Barry Holtz discusses how COVID-19 revealed food|pharma insecurity around the globe.

The Plant is the Bioreactor

From a career spent designing facilities and installing huge stainless steel bioreactors, listen as Bill Brydges describes the quantum leap made by using plants as bioreactors.

  • Home
  • Terms and Conditions